Definitive Contract 75F40120C00136
Award Date
9/29/20
Potential Completion Date
9/29/24
Potential Value
$1.1M
Federal Agency
Food and Drug Administration
Awardee
University Of Connecticut
Ultimate Awardee
Secretary Of State Connecticut
NAICS Category
611310 - Colleges, Universities, and Professional Schools
PSC Category
B529 - Special Studies/Analysis- Scientific Data
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Silver Spring, MD 20903, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The University of Connecticut (UConn) was awarded a $1,310,263 cost-no-fee definitive contract by the Food and Drug Administration (FDA) to enhance and validate in vitro-in vivo correlation (IVIVC) methods for long-acting injectable drug products to accelerate their generic development. The contract is part of the FDA's Broad Agency Announcement for Advanced Regulatory Science, which solicits research and development proposals across various areas to modernize regulatory science and support...
This is a definitive contract awarded by the Food and Drug Administration (FDA) to the University of Connecticut (UConn) for a comparative trial of different packaging components of an opioid packaging solution. The study aims to evaluate the effectiveness of different opioid package designs, patient education messages, and calendar components on prescribing, dispensing, and patient use of oxycodone. The contract, which has a ceiling value of $1,417,987.00, does not have a set-aside designation....
This is a $432,990 firm fixed price contract awarded by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to the University of Connecticut to develop a single-administration microneedle skin patch for novel vaccination technology. The contract supports the national interest in response to the coronavirus pandemic. The University of Connecticut is a public research institution that frequently conducts work for the federal government...
This is a $1,095,703.00 definitive contract awarded by the Department of Health and Human Services Food and Drug Administration to the University of Texas at Austin, a public research university. The contract is for research on the "EFFECT OF REPEAT UNIT ORDERING ON THE PROPERTIES OF MELT-EXTRUDED, POLY(LACTIDE-COGLYCOLIDE)- BASED, LONG-ACTING,IMPLANTS" and has a completion date of September 30, 2024. The contract is a cost-no-fee type and does not utilize a set-aside. As a major...
This federal contract award to the University of Connecticut (UConn) is for the NIH Pain Consortium Centers of Excellence in Pain Education program. The base contract was awarded on September 18, 2015 with a period of performance through September 17, 2016 and a ceiling value of $913,933.75. The contract is a definitive cost-no-fee contract issued by the National Institute on Drug Abuse, a civilian agency under the Department of Health and Human Services. This award does not utilize any...
This is a Firm Fixed Price Blanket Purchase Agreement (BPA) call contract awarded by the Food and Drug Administration (FDA) to Research Triangle Institute (RTI International), a non-profit research organization, for $893,433.00. The contract is for exploring the knowledge and drug preferences of individuals injecting prescription opioids or prescription stimulants. There is no set-aside designation. The contract includes a subcontract to the University of North Carolina at Chapel Hill (UNC-CH)...
The National Institute of Child Health and Human Development (NICHD) awarded a firm-fixed-price purchase order contract to the University of Connecticut Health Center (UCHC) for gene editing services. The contract, valued at $3,882.00, has a completion date of February 28, 2021. UCHC is a state-controlled institution of higher learning that has an extensive portfolio of federal contracts and grants, including work with the Department of Defense and Defense Health Agency on medical training and...
This firm fixed price purchase order contract, valued at $22,610.38, was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh to the University of Connecticut (UConn) to develop resources for designing age-friendly workplaces in manufacturing support. UConn, a non-profit 1862 land-grant educational institution, will leverage its multidisciplinary expertise to support this federal priority. The contract has no set-aside designation. UConn has a broad portfolio of federal...
This is a $500,000 firm-fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to the University of Florida (UF) Division of Sponsored Research for a pharmacokinetic comparison study of locally acting orally inhaled drug products. The contract does not have a set-aside designation, indicating UF competed for and was awarded the contract based on its extensive research capabilities. UF is a major research institution that provides a wide range of goods and services to...
This is a $3,526,785.00 definitive, firm fixed-price contract awarded by the Food and Drug Administration (FDA) to the Regents of the University of Michigan, doing business as the University of Michigan, for Prediction of In Vivo Performance Analysis Services. The contract has no set-aside designation. The University of Michigan is providing a range of research and development services under this contract, including developing high-performance computational models to simulate small intestine...